This inventor holds 4 USPTO granted patents. Top assignees: Microprobe, Inc., Epitope Limited. Active years: 1992-1998.
Location History:
- Bothell, WA (US) (1992)
- Portland, OR (US) (1992 - 1998)
Company Filing History:
Years Active: 1992-1998
Title: B Melina Cimler: Innovator in Nucleic Acid Extraction and Oral Fluid Analysis
Introduction
B Melina Cimler is a notable inventor based in Portland, OR (US). She has made significant contributions to the fields of nucleic acid extraction and oral fluid analysis. With a total of 4 patents to her name, her work has advanced the methodologies used in these critical areas of research and diagnostics.
Latest Patents
Cimler's latest patents include a saliva assay method and device, which presents an improved technique for determining the presence of an analyte in an oral fluid sample. This method involves mixing the sample with a chromogenic substrate that reacts with .alpha.-amylase, producing a colored product. The level of this colored product indicates whether an effective volume of undiluted oral fluid has been collected for analyte detection. Additionally, she has developed non-toxic compositions and methods for the extraction of nucleic acids. This invention focuses on safe and effective methods for isolating nucleic acids from biological mixtures, utilizing an extraction solution that includes organic compounds like benzyl alcohol.
Career Highlights
Throughout her career, Cimler has worked with several companies, including Microprobe, Inc. and Epitope Limited. Her experience in these organizations has contributed to her expertise in the development of innovative solutions in her field.
Collaborations
Cimler has collaborated with notable professionals such as Rich B Meyer, Jr. and Nicolaas M Vermeulen. These partnerships have likely enriched her research and development efforts.
Conclusion
B Melina Cimler's contributions to the fields of nucleic acid extraction and oral fluid analysis demonstrate her innovative spirit and commitment to advancing scientific knowledge. Her patents reflect her dedication to improving diagnostic methods and enhancing research capabilities.